Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit.

Alexandre de NonnevilleCamille JauffretAnthony GonçalvesJean-Marc ClasseMonique CohenFabien ReyalChafika MazouniMarie-Pierre ChauvetNicolas ChopinPierre-Emmanuel ColomboEva JouveEmile DaraiRoman RouzierCharles CoutantPierre GimberguesAnne-Sophie AzuarChristine Tunon de LaraEric LambaudieGilles Houvenaeghel

Published in: Breast cancer research and treatment (2019)

ILC patients could derive significant DFS and OS benefits from CT, especially for high-risk patients.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
computed tomography
peritoneal dialysis
magnetic resonance
dna methylation